Could less treatment be just as good? cancer trial tests new approach
NCT ID NCT05923190
Summary
This study is testing whether giving two approved bladder cancer drugs less frequently can still control the disease while potentially reducing side effects. It involves 60 adults with advanced bladder cancer that has spread or cannot be surgically removed. The main goal is to see if a reduced treatment schedule maintains the same benefits as the standard schedule.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC UROTHELIAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fox Chase Cancer Center - Philadelphia
Philadelphia, Pennsylvania, 19111-2497, United States
Conditions
Explore the condition pages connected to this study.